Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James N Fullerton

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Critical Care Medicine|May 16, 2015
Increased mortality in "cold sepsis": the result of a frozen immune response?James N Fullerton
Resuscitation|March 26, 2013
Oxygen in resuscitation: a game of two halvesJames N Fullerton
BMJ (Clinical Research Ed.)|August 13, 2013
Use of non-steroidal anti-inflammatory drugs (NSAIDs) as immunomodulatory agentsJames N Fullerton
Seminars in Respiratory and Critical Care Medicine|October 13, 2011
Organ failure in the ICU: cellular alterationsJames N Fullerton, Mervyn Singer
Shock (Augusta, Ga.)|April 19, 2016
Stimulated Whole Blood Cytokine Release as a Biomarker of Immunosuppression in the Critically Ill: The Need for a Standardized MethodologyElisabetta Segre, James N Fullerton
Nature Reviews. Drug Discovery|March 30, 2016
Resolution of inflammation: a new therapeutic frontierJames N Fullerton, Derek W Gilroy
British Journal of Clinical Pharmacology|October 20, 2020
Model antibiotic use to improve outcomesJames N Fullerton, Oscar Della Pasqua, Robert Likic
Resuscitation|September 8, 2009
Can experienced paramedics perform tracheal intubation at cardiac arrests? Five years experience of a regional air ambulance service in the UKJames N Fullerton, Keith J Roberts, Matthew Wyse
The Journal of Pathology|June 25, 2013
Pathways mediating resolution of inflammation: when enough is too muchJames N Fullerton, Alastair J O'Brien, Derek W Gilroy
Trends in Immunology|November 26, 2013
Lipid mediators in immune dysfunction after severe inflammationJames N Fullerton, Alastair J O'Brien, Derek W Gilroy
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Critical Care Medicine|May 16, 2015
Increased mortality in "cold sepsis": the result of a frozen immune response?James N Fullerton
Resuscitation|March 26, 2013
Oxygen in resuscitation: a game of two halvesJames N Fullerton
BMJ (Clinical Research Ed.)|August 13, 2013
Use of non-steroidal anti-inflammatory drugs (NSAIDs) as immunomodulatory agentsJames N Fullerton
Seminars in Respiratory and Critical Care Medicine|October 13, 2011
Organ failure in the ICU: cellular alterationsJames N Fullerton, Mervyn Singer
Shock (Augusta, Ga.)|April 19, 2016
Stimulated Whole Blood Cytokine Release as a Biomarker of Immunosuppression in the Critically Ill: The Need for a Standardized MethodologyElisabetta Segre, James N Fullerton
Nature Reviews. Drug Discovery|March 30, 2016
Resolution of inflammation: a new therapeutic frontierJames N Fullerton, Derek W Gilroy
British Journal of Clinical Pharmacology|October 20, 2020
Model antibiotic use to improve outcomesJames N Fullerton, Oscar Della Pasqua, Robert Likic
Resuscitation|September 8, 2009
Can experienced paramedics perform tracheal intubation at cardiac arrests? Five years experience of a regional air ambulance service in the UKJames N Fullerton, Keith J Roberts, Matthew Wyse
The Journal of Pathology|June 25, 2013
Pathways mediating resolution of inflammation: when enough is too muchJames N Fullerton, Alastair J O'Brien, Derek W Gilroy
Trends in Immunology|November 26, 2013
Lipid mediators in immune dysfunction after severe inflammationJames N Fullerton, Alastair J O'Brien, Derek W Gilroy
Pageof 3